Hepatocellular carcinoma (HCC) is a global problem constituting the second leading cause
of cancer deaths worldwide, thereby necessitating an accurate and cost-effective solution for …

Hepatocellular carcinoma (HCC) remains the most common form of liver cancer, accounting
for 90% of all primary liver cancers. Up to 30% of HCC cases could be small (2–3 cm in …

The application of trans-arterial radioembolization (TARE) with Yttrium-90, historically a
palliative treatment option for patients with advanced hepatocellular carcinoma (HCC), is …

Purpose To investigate the outcomes of radiation segmentectomy (RS) versus standard-of-
care surgical resection (SR). Materials and Methods A multisite, retrospective analysis of …

Background Microwave ablation (MWA) has become the standard thermal-based treatment
for hepatic malignancies in patients who have unresectable disease based on the biology of …

Primary liver malignancy, of which hepatocellular carcinoma (HCC) is the most common
type, is the second most common cause of death due to cancer worldwide. Given the …

Simple Summary This article is an overview of the technique, indications, and outcomes of
transarterial yttrium-90 radiation segmentectomy for the treatment of hepatocellular …

Purpose Transarterial radioembolization can serve as an ablative therapy for early-stage
hepatocellular carcinoma (HCC). Given the volumetric variability of liver segments, this study …

Hepatocellular carcinoma remains a prominent cause of cancer-related mortality globally.
Transarterial yttrium-90 radioembolization is a versatile therapy and plays an important role …

Purpose To identify factors of incomplete treatment after segmental transarterial
radioembolization (TARE) for treatment-naive and solitary hepatocellular carcinoma (HCC) …